Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(643/week)
Manufacturing
(442/week)
Energy
(369/week)
Technology
(457/week)
Other Manufacturing
(373/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Opioid antagonists
Jun 22, 2020
New Preclinical Data on ALKS 4230 in Combination With Lucitanib to be Presented at 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
Jun 01, 2020
Camurus Announces Submission of Request for Final Approval of Brixadi(TM) for the Treatment of Opioid Use Disorder in the US
Jun 01, 2020
Braeburn Submits Request for Final Approval of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
Mar 04, 2020
Journal of Clinical Psychiatry Publishes Data from Alkermes' Phase 3 ENLIGHTEN-1 Efficacy Study of ALKS 3831 in Patients With Schizophrenia
Jan 29, 2020
Promising Results From Human PK Study Assessing Novel Ketorolac Formulations for Treatment of Pain
Jan 28, 2020
Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder
Jan 07, 2020
Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Digital Technology to Improve Medication-Assisted Treatment in Primary Care
Dec 02, 2019
New Analysis From One-Year Study of Monthly Buprenorphine Extended-Release Injections Showed Improved or Stable Patient-Centered Outcomes
Nov 25, 2019
Camurus Announces New Study Results Showing Superior Patient Reported Outcomes With Buvidal® Versus Standard of Care in Treatment of Opioid Dependence
Nov 19, 2019
Alkermes Submits New Drug Application to U.S. Food and Drug Administration for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder
Nov 04, 2019
Alkermes to Present Data From ALKS 4230 Clinical Development Program at the Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting
Oct 18, 2019
Global Opioid Overdose Pipeline Insights Report 2019
Oct 01, 2019
SaVida Health, a Leading Provider of Outpatient Opioid and Alcohol Addiction Treatment Services, Opens in West Springfield, MA
Sep 20, 2019
Statement from Acting FDA Commissioner Ned Sharpless, M.D., on continued efforts to increase availability of all forms of naloxone to help reduce opioid overdose deaths
Sep 12, 2019
Comagine Health participates in study to reduce the risk of post-incarceration opioid overdose in women
Sep 11, 2019
In fight to end nation's opioid crisis, a new treatment approach emerges
Aug 08, 2019
BayMark Health Services Opens AppleGate Recovery In Blacksburg, Va
Jul 30, 2019
The Government of Canada increases access to treatment for opioid use disorder in Alberta
Jul 29, 2019
Online Platform Provides Life-Saving Opioid Antidote; Expands To Pennsylvania & West Virginia On August 1
Jul 23, 2019
Camurus Announces Positive Outcome of U.S. Court Proceeding About Final Approval of Brixadi(TM)
Page 1
››
Latest News
May 9, 2024
SunOpta Announces First Quarter Fiscal 2024 Financial Results
May 9, 2024
Vista Outdoor Reports Strong Fourth Quarter Financial Results and Fiscal Year 2024 Financial Results
May 9, 2024
Allient Reports Gross and Operating Margin Expansion on Revenue of $146.7 Million in First Quarter 2024
May 9, 2024
Trinseo Reports First Quarter 2024 Financial Results and Provides Second Quarter Outlook
May 9, 2024
Allient Declares Quarterly Cash Dividend
May 9, 2024
Fortive to Present at the Wolfe Research Global Transportation and Industrials Conference
May 9, 2024
Texas Pacific Land Corporation Announces First Quarter Results and Record Water Segment Revenues
May 9, 2024
Celanese Corporation Reports First Quarter Earnings
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events